Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT02164513

Public ClinicalTrials.gov record NCT02164513. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, 52 Week, Randomized, Double-blind, 3-arm Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination FF/UMEC/VI With the Fixed Dose Dual Combinations of FF/VI and UMEC/VI, All Administered Once-daily in the Morning Via a Dry Powder Inhaler in Subjects With Chronic Obstructive Pulmonary Disease

Study identification

NCT ID
NCT02164513
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
10,355 participants

Conditions and interventions

Interventions

  • fluticasone furoate (FF) Drug
  • vilanterol (VI) Drug
  • umeclidinium bromide (UMEC) Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2014
Primary completion
Jul 16, 2017
Completion
Jul 16, 2017
Last update posted
Oct 9, 2018

2014 – 2017

United States locations

U.S. sites
269
U.S. states
38
U.S. cities
229
Facility City State ZIP Site status
GSK Investigational Site Athens Alabama 35611
GSK Investigational Site Birmingham Alabama 35215
GSK Investigational Site Birmingham Alabama 35216
GSK Investigational Site Birmingham Alabama 35294
GSK Investigational Site Florence Alabama 35630
GSK Investigational Site Jasper Alabama 35501
GSK Investigational Site Mobile Alabama 36608
GSK Investigational Site Muscle Shoals Alabama 35662
GSK Investigational Site Sheffield Alabama 35660
GSK Investigational Site Chandler Arizona 85284
GSK Investigational Site Flagstaff Arizona 86001
GSK Investigational Site Glendale Arizona 85306
GSK Investigational Site Peoria Arizona 85381
GSK Investigational Site Phoenix Arizona 85018
GSK Investigational Site Phoenix Arizona 85032
GSK Investigational Site Tucson Arizona 85723
GSK Investigational Site Tucson Arizona 85724-5023
GSK Investigational Site Tucson Arizona 85745
GSK Investigational Site Arcadia California 91007
GSK Investigational Site Bakersfield California 93301
GSK Investigational Site Chula Vista California 91910
GSK Investigational Site Encinitas California 92024
GSK Investigational Site Escondido California 92025
GSK Investigational Site Huntington Beach California 92647
GSK Investigational Site Long Beach California 90808
GSK Investigational Site Long Beach California 90822
GSK Investigational Site Mission Hills California 91345
GSK Investigational Site Modesto California 95350
GSK Investigational Site Newport Beach California 92663
GSK Investigational Site Palo Alto California 94304
GSK Investigational Site Reseda California 91335
GSK Investigational Site Riverside California 92506
GSK Investigational Site Rolling Hills Estates California 90274
GSK Investigational Site Sacramento California 95821
GSK Investigational Site San Diego California 92117
GSK Investigational Site Santa Ana California 92705
GSK Investigational Site Santa Monica California 90404
GSK Investigational Site Torrance California 90505
GSK Investigational Site Tustin California 92780
GSK Investigational Site Upland California 91786
GSK Investigational Site Vista California 92083
GSK Investigational Site Boulder Colorado 80301
GSK Investigational Site Colorado Springs Colorado 80907
GSK Investigational Site Fort Collins Colorado 80538
GSK Investigational Site Golden Colorado 80401
GSK Investigational Site Danbury Connecticut 06810
GSK Investigational Site Hartford Connecticut 06105
GSK Investigational Site New Haven Connecticut 06520
GSK Investigational Site Stamford Connecticut 06902
GSK Investigational Site Waterbury Connecticut 06708
GSK Investigational Site West Haven Connecticut 06516
GSK Investigational Site Bay Pines Florida 33744
GSK Investigational Site Boynton Beach Florida 33436
GSK Investigational Site Brandon Florida 33511
GSK Investigational Site Celebration Florida 34747
GSK Investigational Site Clearwater Florida 33759
GSK Investigational Site Clearwater Florida 33765-2616
GSK Investigational Site Daytona Beach Florida 32117
GSK Investigational Site DeLand Florida 32720
GSK Investigational Site Edgewater Florida 32132
GSK Investigational Site Fort Lauderdale Florida 33306
GSK Investigational Site Fort Myers Florida 33908
GSK Investigational Site Gainesville Florida 32608
GSK Investigational Site Hollywood Florida 33024
GSK Investigational Site Jacksonville Florida 32204
GSK Investigational Site Jacksonville Florida 32205
GSK Investigational Site Jacksonville Florida 32207
GSK Investigational Site Jacksonville Florida 32209
GSK Investigational Site Jacksonville Florida 32216
GSK Investigational Site Leesburg Florida 34748
GSK Investigational Site Loxahatchee Groves Florida 33470
GSK Investigational Site Maitland Florida 32751
GSK Investigational Site Miami Florida 33015
GSK Investigational Site Miami Florida 33137
GSK Investigational Site New Port Richey Florida 34652
GSK Investigational Site Orlando Florida 32825
GSK Investigational Site Oviedo Florida 32765
GSK Investigational Site Pembroke Pines Florida 33027
GSK Investigational Site Pensacola Florida 32503
GSK Investigational Site Ponte Vedra Beach Florida 32081
GSK Investigational Site Port Charlotte Florida 33952
GSK Investigational Site Port Charlotte Florida 33980
GSK Investigational Site Port Orange Florida 32127
GSK Investigational Site Sarasota Florida 34239
GSK Investigational Site St. Petersburg Florida 33704
GSK Investigational Site Tampa Florida 33603
GSK Investigational Site Adairsville Georgia 30103
GSK Investigational Site Athens Georgia 30606
GSK Investigational Site Austell Georgia 30106
GSK Investigational Site Columbus Georgia 31904
GSK Investigational Site Conyers Georgia 30094
GSK Investigational Site Decatur Georgia 30033
GSK Investigational Site Duluth Georgia 30096
GSK Investigational Site Gainesville Georgia 30501
GSK Investigational Site Marietta Georgia 30060
GSK Investigational Site Rincon Georgia 31326
GSK Investigational Site Woodstock Georgia 30189
GSK Investigational Site Coeur d'Alene Idaho 83814
GSK Investigational Site Chicago Illinois 60611
GSK Investigational Site Elk Grove Village Illinois 60007
GSK Investigational Site Gillespie Illinois 62033
GSK Investigational Site Hines Illinois 60124
GSK Investigational Site O'Fallon Illinois 62269
GSK Investigational Site Oak Park Illinois 60302
GSK Investigational Site Quincy Illinois 62301
GSK Investigational Site Winfield Illinois 60190
GSK Investigational Site Evansville Indiana 47714
GSK Investigational Site Franklin Indiana 46131
GSK Investigational Site Greenfield Indiana 46140
GSK Investigational Site Muncie Indiana 47303
GSK Investigational Site Council Bluffs Iowa 51503
GSK Investigational Site Iowa City Iowa 52242
GSK Investigational Site Olathe Kansas 66061
GSK Investigational Site Topeka Kansas 66606
GSK Investigational Site Wichita Kansas 67218
GSK Investigational Site Fort Mitchell Kentucky 41017
GSK Investigational Site Louisville Kentucky 40218
GSK Investigational Site Paducah Kentucky 42003
GSK Investigational Site Crowley Louisiana 70526
GSK Investigational Site Lafayette Louisiana 70508
GSK Investigational Site New Orleans Louisiana 70112
GSK Investigational Site New Orleans Louisiana 70115
GSK Investigational Site New Orleans Louisiana 70119
GSK Investigational Site Shreveport Louisiana 71103
GSK Investigational Site Sunset Louisiana 70584
GSK Investigational Site Bangor Maine 04401
GSK Investigational Site Columbia Maryland 21044
GSK Investigational Site Hollywood Maryland 20636
GSK Investigational Site Fall River Massachusetts 02720
GSK Investigational Site North Dartmouth Massachusetts 02747
GSK Investigational Site Pittsfield Massachusetts 01201
GSK Investigational Site Worcester Massachusetts 01608
GSK Investigational Site Ann Arbor Michigan 48106
GSK Investigational Site Southfield Michigan 48034
GSK Investigational Site Troy Michigan 48085
GSK Investigational Site Duluth Minnesota 55805
GSK Investigational Site Edina Minnesota 55435
GSK Investigational Site Fridley Minnesota 55432
GSK Investigational Site Minneapolis Minnesota 55402
GSK Investigational Site Minneapolis Minnesota 55407
GSK Investigational Site Rochester Minnesota 55905
GSK Investigational Site Saint Paul Minnesota 55130
GSK Investigational Site Woodbury Minnesota 55125
GSK Investigational Site Jackson Mississippi 39202
GSK Investigational Site Chesterfield Missouri 63017
GSK Investigational Site Kansas City Missouri 64128
GSK Investigational Site Saint Charles Missouri 63301
GSK Investigational Site St Louis Missouri 63141
GSK Investigational Site Butte Montana 59701
GSK Investigational Site Missoula Montana 59808
GSK Investigational Site Fremont Nebraska 68025
GSK Investigational Site Grand Island Nebraska 68803
GSK Investigational Site Lincoln Nebraska 68506
GSK Investigational Site Omaha Nebraska 68131
GSK Investigational Site Omaha Nebraska 68134
GSK Investigational Site Las Vegas Nevada 89106
GSK Investigational Site Reno Nevada 89503
GSK Investigational Site Marlton New Jersey 08053
GSK Investigational Site Moorestown New Jersey 08057
GSK Investigational Site Neptune City New Jersey 07753
GSK Investigational Site Albuquerque New Mexico 87108
GSK Investigational Site Albany New York 12208
GSK Investigational Site Bronxville New York 10708
GSK Investigational Site New York New York 10009
GSK Investigational Site New York New York 10016
GSK Investigational Site New York New York 10029
GSK Investigational Site Syracuse New York 13210
GSK Investigational Site The Bronx New York 10457
GSK Investigational Site The Bronx New York 10461
GSK Investigational Site Asheville North Carolina 28801
GSK Investigational Site Calabash North Carolina 28467
GSK Investigational Site Charlotte North Carolina 28207
GSK Investigational Site Charlotte North Carolina 28262
GSK Investigational Site Charlotte North Carolina 28277
GSK Investigational Site Durham North Carolina 27710
GSK Investigational Site Elizabeth City North Carolina 27909
GSK Investigational Site Gastonia North Carolina 28054
GSK Investigational Site Greensboro North Carolina 27403
GSK Investigational Site Hendersonville North Carolina 28739
GSK Investigational Site Huntersville North Carolina 28078
GSK Investigational Site Lexington North Carolina 27292
GSK Investigational Site Mooresville North Carolina 28117
GSK Investigational Site Shelby North Carolina 28150
GSK Investigational Site Shelby North Carolina 28152
GSK Investigational Site Tabor City North Carolina 28463
GSK Investigational Site Whiteville North Carolina 28472
GSK Investigational Site Wilmington North Carolina 28401
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Canton Ohio 44718
GSK Investigational Site Cincinnati Ohio 45220
GSK Investigational Site Cincinnati Ohio 45231
GSK Investigational Site Cincinnati Ohio 45245
GSK Investigational Site Columbus Ohio 43213
GSK Investigational Site Dayton Ohio 45459
GSK Investigational Site Marion Ohio 43302
GSK Investigational Site Middleburg Heights Ohio 44130
GSK Investigational Site Toledo Ohio 43606
GSK Investigational Site Toledo Ohio 43617
GSK Investigational Site Wooster Ohio 44691
GSK Investigational Site Corvallis Oregon 97330
GSK Investigational Site Medford Oregon 97504
GSK Investigational Site Portland Oregon 97220
GSK Investigational Site Portland Oregon 97225
GSK Investigational Site Portland Oregon 97239
GSK Investigational Site Downingtown Pennsylvania 19335
GSK Investigational Site Doylestown Pennsylvania 18901
GSK Investigational Site Erie Pennsylvania 16508
GSK Investigational Site Johnstown Pennsylvania 15905
GSK Investigational Site Philadelphia Pennsylvania 19107
GSK Investigational Site Philadelphia Pennsylvania 19140
GSK Investigational Site Philadelphia Pennsylvania 19142
GSK Investigational Site Phoenixville Pennsylvania 19460
GSK Investigational Site Pittsburgh Pennsylvania 15213
GSK Investigational Site Pittsburgh Pennsylvania 15241
GSK Investigational Site Pittsburgh Pennsylvania 15243
GSK Investigational Site Tipton Pennsylvania 16684
GSK Investigational Site Wyomissing Pennsylvania 19610
GSK Investigational Site East Providence Rhode Island 02914
GSK Investigational Site Anderson South Carolina 29621
GSK Investigational Site Charleston South Carolina 29406-7108
GSK Investigational Site Columbia South Carolina 29204
GSK Investigational Site Columbia South Carolina 29209
GSK Investigational Site Easley South Carolina 29640
GSK Investigational Site Fort Mill South Carolina 29707
GSK Investigational Site Gaffney South Carolina 29340
GSK Investigational Site Gaffney South Carolina 29341
GSK Investigational Site Greenville South Carolina 29615
GSK Investigational Site Mt. Pleasant South Carolina 29464
GSK Investigational Site Rock Hill South Carolina 29732
GSK Investigational Site Seneca South Carolina 29678
GSK Investigational Site Spartanburg South Carolina 29303
GSK Investigational Site Union South Carolina 29379
GSK Investigational Site Rapid City South Dakota 57702
GSK Investigational Site Sioux Falls South Dakota 57108
GSK Investigational Site Chattanooga Tennessee 37404
GSK Investigational Site Hendersonville Tennessee 37075
GSK Investigational Site Johnson City Tennessee 37601
GSK Investigational Site Corsicana Texas 75110
GSK Investigational Site Edinburg Texas 78539
GSK Investigational Site Fort Worth Texas 76104
GSK Investigational Site Gonzales Texas 78629
GSK Investigational Site Houston Texas 77030
GSK Investigational Site Houston Texas 77034
GSK Investigational Site Houston Texas 77043
GSK Investigational Site Katy Texas 77450
GSK Investigational Site Kerrville Texas 78028
GSK Investigational Site Kingwood Texas 77339
GSK Investigational Site Lewisville Texas 75067
GSK Investigational Site Longview Texas 75605
GSK Investigational Site Plano Texas 75093
GSK Investigational Site San Antonio Texas 78215
GSK Investigational Site San Antonio Texas 78229
GSK Investigational Site Sealy Texas 77474
GSK Investigational Site Sugar Land Texas 77479
GSK Investigational Site Tomball Texas 77375
GSK Investigational Site Abingdon Virginia 24210
GSK Investigational Site Hampton Virginia 23666
GSK Investigational Site Lynchburg Virginia 24501
GSK Investigational Site Richmond Virginia 23225
GSK Investigational Site Richmond Virginia 23229
GSK Investigational Site Richmond Virginia 23249
GSK Investigational Site Virginia Beach Virginia 23454
GSK Investigational Site Bellingham Washington 98225
GSK Investigational Site Everett Washington 98208
GSK Investigational Site Renton Washington 98055
GSK Investigational Site Renton Washington 98057
GSK Investigational Site Seattle Washington 98122
GSK Investigational Site Spokane Valley Washington 99216
GSK Investigational Site Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 729 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02164513, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2018 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02164513 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →